Healthcare Active Stocks: Peregrine Pharmaceuticals (NASDAQ:PPHM), Merck & Co (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA), Abbott Laboratories (NYSE:ABT)

FB Nasdaq FB Facebook

Shares of Peregrine Pharmaceuticals (NASDAQ: PPHM ) , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer, dipped as much as 11% after reporting its third-quarter earnings results. Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was -8.05% in last session and finished the day at $2.40. Traded volume was 14.14million shares in the last session and the average volume of the stock remained 4.31million shares. The beta of the stock remained 1.40. Peregrine Pharmaceuticals (NASDAQ:PPHM) insider ownership is 0.20%.

Merck & Co., Inc. (NYSE:MRK) was the most admired corporation in America — but even at Merck at the time that Boger left, the chemists reported to me, there were benchmarks and goals set; numbers of compounds made, for instance, in a program. It didn’t matter whether they were an improvement over anything else. Merck & Co., Inc. (NYSE:MRK) Rose 0.37 percent to $57.47 Friday on volume of 10.63million shares. The intra-day range of the stock was $57.10 to $57.57. Merck & Co., Inc. (NYSE:MRK) has a market capitalization of $169.00billion.

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announces the launch of the generic equivalent to Xeloda® (Capecitabine) Tablets, 150 MG and 500 MG, in the United States. Xeloda® is marketed by Genentech in the United States. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)’s stock on Mar 7, 2014 reported a decrease of -1.04% to the closing price of $49.30. Its fifty two weeks range is $36.26-$51.41. The total market capitalization recorded $46.76billion. The overall volume in the last trading session was 10.38million shares. In its share capital, TEVA has 847.00million outstanding shares.

A Lewiston couple sat shame-faced in an Androscoggin County courtroom last week as a judge pronounced them guilty of stealing about $20,000 in housing benefits intended for the poor. Abbott Laboratories (NYSE:ABT), meanwhile, paid Maine $1,607,808 in another settlement the same year. On Friday, shares of Abbott Laboratories (NYSE:ABT) dropped -0.40% to close the day at $39.57. Company return on investment (ROI) is 8.00% and its monthly performance is recorded as 8.86%. Abbott Laboratories (NYSE:ABT) quarterly revenue growth is 6.51%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone